PHARMACOLOGIC TOPOISOMERASE-I INHIBITION CAUSES DNA DAMAGE AND MORTALITY IN ACTIVATED CD4+ T CELLS. (2018). Genetics & Applications, 2(2), 51-56. https://doi.org/10.31383/ga.vol2iss2pp51-56